Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Ernest Y.-Z. Tan Clear advanced filters

  • Ultrafast excitation of materials can cause the formation of hidden phases that are not accessible in thermal equilibrium. Li et al. identify and investigate theoretically a hidden phase that can be accessed in systems with intertwined spin and orbital-ordering such as KCuF3.

    • Jiajun Li
    • Hugo U. R. Strand
    • Martin Eckstein
    ResearchOpen Access
    Nature Communications
    Volume: 9, P: 1-7

  • There are no vaccines or antivirals available against enterovirus D68. Here, the authors report Jun6504 as a 2C inhibitor and show that it provides broad-spectrum antiviral activity against EV-D68, EV-A71, and CVB3 and potent antiviral efficacy in a neonatal neurological mouse model of EV-D68 infection.

    • Kan Li
    • Michael J. Rudy
    • Jun Wang
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-18

  • Device-independent quantum key distribution aims at the ultimate quantum-based unconditional security, but current protocols’ rates are quite far from anything practical. The authors’ protocol narrows this gap by using two randomly chosen key generating bases instead of one.

    • René Schwonnek
    • Koon Tong Goh
    • Charles C.-W. Lim
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-8

  • In this Stage 2 Registered Report, Buchanan et al. show evidence confirming the phenomenon of semantic priming across speakers of 19 diverse languages.

    • Erin M. Buchanan
    • Kelly Cuccolo
    • Savannah C. Lewis
    Research
    Nature Human Behaviour
    Volume: 10, P: 182-201

  • Patients with acute myeloid leukaemia are often unable to tolerate intensive chemotherapy, and the outcomes of these patients have improved considerably following the availability of regimens containing the BH3 mimetic venetoclax. Nonetheless, not all of these patients will respond to venetoclax, and virtually all will ultimately develop resistance, indicating a need for novel treatment strategies targeting this pathway. In this Review, the authors describe the development of BCL-2 inhibitors, discuss mechanisms of resistance and summarize ongoing research efforts aimed at optimizing the therapeutic benefit of these agents.

    • Antonino Glaviano
    • Ellen Weisberg
    • Alan P. Kumar
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 22, P: 847-868